Form 13-F position report

UNITY BIOTECHNOLOGY INC

Reported by RENAISSANCE TECHNOLOGIES LLC

UBX CUSIP 91381U101 Manager CIK 0001037389

Reported 0 shares, down 1,582,369 (100.0%) from the prior quarter.

Reported value -100.0%; share count -100.0% vs. the prior quarter.

Reduced
% of reported 13F value 0 This manager · Q4 2022
Shares 0 Quarter-end amount reported
Reported value $0 Fair value at quarter end
Consecutive quarters held 7 Through Q4 2022

Reported position value by quarter

Reported position value by quarter

Each bar is a Form 13-F quarter-end snapshot. It does not show trades made within the quarter.

Reported position value by quarter
Date Holding Value
2021-09-30 1922000
2021-12-31 1573000
2022-03-31 1016000
2022-06-30 540000
2022-09-30 625000
2022-12-31 0

Quarterly position history

How this manager's reported quarter-end position changed over time.

6 quarters
Quarterly reported position history for UNITY BIOTECHNOLOGY INC held by RENAISSANCE TECHNOLOGIES LLC.
Quarter Activity Shares Change % of reported 13F Reported value Filed Source filing
Q4 2022 Reduced 0 -1,582,369 (-100.0%) 0 $0 2023-02-13
Q3 2022 Added 1,582,369 +624,651 (65.2%) < 0.01% $625,000 2022-11-14
Q2 2022 Added 957,718 +51,003 (5.6%) < 0.01% $540,000 2022-08-12
Q1 2022 Reduced 906,715 -170,985 (-15.9%) < 0.01% $1,016,000 2022-05-13
Q4 2021 Added 1,077,700 +437,000 (68.2%) < 0.01% $1,573,000 2022-02-11
Q3 2021 Added 640,700 +128,100 (25.0%) < 0.01% $1,922,000 2021-11-12
Five years are shown. A free account unlocks the complete reported history. Unlock full history

Who else reported the position

66 managers reported UNITY BIOTECHNOLOGY INC for Q4 2022.

Managers reporting UNITY BIOTECHNOLOGY INC in Q4 2022.
Manager Activity Shares Change % of reported 13F Reported value Tenure
Mayo Clinic Unchanged 157,198 0 0.23% $430,723 1 qtr
Rosenberg Matthew Hamilton New 200 +200 < 0.01% $548 1 qtr
VICTORY CAPITAL MANAGEMENT INC Reduced 0 -14,010 0 $0 2 qtrs
BNP PARIBAS FINANCIAL MARKETS Reduced 0 -74 0 $0 18 qtrs
Laurion Capital Management LP Reduced 0 -700,000 0 $0 2 qtrs
THE BANK OF NEW YORK MELLON CORPORATION Reduced 0 -22,620 0 $0 19 qtrs
TRUE Private Wealth Advisors Reduced 0 -15,740 0 $0 4 qtrs
Virtu Financial LLC Reduced 0 -35,098 0 $0 5 qtrs
ROYAL BANK OF CANADA Reduced 0 -1,663 0 $0 19 qtrs
BlackRock Inc Reduced 0 -563,488 0 $0 19 qtrs
Premium adds each manager's conviction percentile across reporting peers.
Filing details and methodology As reported
Report period
December 31, 2022
Filed
February 13, 2023
Filing type
13F-HR
Position type
COM

Voting authority reported

No voting-authority amounts were reported for this position. Voting authority is not required for reported call options.

Form 13-F is a delayed quarter-end snapshot of disclosed long Section 13(f) securities. It can be filed up to 45 days after quarter end, excludes short positions and most non-U.S. securities, and does not reveal intra-quarter trading. For options, reported shares and value describe the underlying-share exposure; strike, expiry, premium, and written positions are not disclosed.